Published in Blood · View the paper (DOI)
A study by University of Utah Health and PEEL Therapeutics found that an overactive NET immune response may lead to increased blood clotting, disease severity, and death from COVID-19. A naturally occurring protein, nNIF, quiets this hyperactive response, potentially opening new avenues for treatment.
Coverage from 2 institutions